Haemonetics (HAE) Retained Earnings (2010 - 2026)

Haemonetics' Retained Earnings history runs 17 years deep, the most recent figure standing at $279.3 million for Q1 2026.

• On a quarterly basis, Retained Earnings rose 607.12% year-over-year to $279.3 million in Q1 2026; TTM through Mar 2026 was $279.3 million, a 607.12% increase from a year earlier, with the FY2026 full-year figure at $279.3 million, up 607.12% from the prior year.
• Retained Earnings declined to $279.3 million in Q1 2026 per HAE's latest filing, from $381.1 million in the prior quarter.
• Across five years, Retained Earnings topped out at $392.2 million in Q4 2024 and bottomed at -$55.1 million in Q1 2025.
• The 5-year median for Retained Earnings is -$27.7 million (2022), against an average of $89.9 million.
• Across the five-year window, Retained Earnings sank 118.58% in 2022 and surged 1708.69% in 2024, its largest moves.
• Year by year, Retained Earnings stood at -$35.8 million in 2022, then soared by 31.89% to -$24.4 million in 2023, then jumped by 1708.69% to $392.2 million in 2024, then declined by 2.84% to $381.1 million in 2025, then declined by 26.7% to $279.3 million in 2026.
• Per Business Quant, the three latest HAE Retained Earnings figures stand at $279.3 million (Q1 2026), $381.1 million (Q4 2025), and -$40.5 million (Q3 2025).